🕵️ Biorestorative Therapies, Inc. ($BRTX)
SEC insider & ownership activity, last 12 months · CIK 1505497 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Alstodt Lance | 15.5% | 13D | Feb 14, 2025 | filing ↗ | |
| Silva, Francisco | 15.1% | 13D | Feb 14, 2025 | filing ↗ | |
| Auctus Fund, LLC | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Auctus Fund Management LLC | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Alfred Sollami | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Louis Posner | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| ALTA Partners LLC | 7.7% | 13G | Feb 13, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jul 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 8, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 26, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 26, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 1, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 23, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 11, 2026 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 6, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Oct 6, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 6, 2025 | filing ↗ |
| Shareholder vote (5.07) | Sep 18, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 14, 2025 | filing ↗ |
| Earnings (2.02) | Aug 12, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2025 | filing ↗ |